- Fas/CD95, Lipid Rafts, and Cancer
Faustino Mollinedo et al, 2017, TRAIL, Fas Ligand, TNF and TLR3 in Cancer CrossRef - Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells
Leonie De Wilt et al, 2024, Cancer Drug Resistance CrossRef